Fact: Milligrams on a label do not equal milligrams in the blood
The full therapeutic benefit of retatrutide is generally observed at higher maintenance doses, which are reached gradually over several weeks or months
Gasiorek A, Heydorn A, Gabery S et al (2025) Safety, tolerability, pharmacokinetics, and pharmacodynamics of the first-in-class GLP-1 and amylin receptor agonist, amycretin: a first-in-human, phase 1, double-blind, randomised, placebo-controlled trial
On GLP-1s, appetite changes can influence how much food feels comfortable at each meal
To date, there is no reliable evidence that weight loss patches are effective in humans, and the FDA does not regulate their quality or safety